Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells

Journal of Virology

Volumn 73, Issue 5, 1999, Pages 4029-4041

  Monini, Paolo ^a   Carlini, Francesca ^a   Stürzl, Michael ^b,c   Rimessi, Paola ^d   Superti, Fabiana ^a   Franco, Marina ^a   Melucci Vigo, Gianna ^a   Cafaro, Aurelio ^a   Goletti, Delia ^a   Sgadari, Cecilia ^a   Butto', Stefano ^a   Leone, Patrizia ^a   Leone, Pasqualina ^a   Chiozzini, Chiara ^a   Barresi, Caterina ^e   Tinari, Antonella ^a   Bonaccorsi, Angela ^d   Capobianchi, Maria R ^e   Giuliani, Massimo ^a   Di Carlo, Aldo ^a   Andreoni, Massimo ^f   Rezza, Giovanni ^a   Ensoli, Barbara ^a,g   more..

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF FERRARA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DIDANOSINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDINAVIR; PACLITAXEL; RECOMBINANT ALPHA2A INTERFERON; RITONAVIR; SAQUINAVIR; STAVUDINE; VINCRISTINE; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; COMORBIDITY; DRUG EFFECT; HERPES; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT VIRUS INFECTION; LYMPHOMA; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS REACTIVATION;

EID: 0032923485     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.5.4029-4041.1999     Document Type: Article

References (91)

1. Aebi, M., J. Fab, N. Hurt, C. E. Samuel, D. Thomis, L. Bazzigher. J. Pavlovoc, O. Haller, and P. Staeheli. 1989. cDNA structures and regulation of two interferon-induced Mx proteins. Mol. Cell. Biol. 9:5062-5072.
2. Altinkilic, B., and G. Brandner. 1988. Interferon inhibits herpes simplex virus-specific translation: a reinvestigation. J. Gen. Virol. 69:3107-3112.
3. Ambroziak, J. A., D. J. Blackbourn, B. G. Herndier, R. G. Glogau, J. H. Gullett, A. R. McDonald, E. T. Lennette, and J. A. Levy. 1995. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 268:582-583.
4. Antonelli, G., E. Simeoni, M. Solmone, L. Antonelli, G. Iaiani, and F. Dianzani. 1996. In vitro and in vivo detection of IFN-induced MxA and MxB mRNA by RT-PCR. Eur. Cytokine Net. 7:494.
5. Arnhetier, H., S. Skuntz, M. Noteborn, S. Chang, and E. Meier. 1990. Transgenic mice with intracellular immunity to influenza virus. Cell 62:51-61.
6. Bais, C., B. Santomasso, O. Coso, L. Arvanitakis, E. G. Raaka, J. S. Gutkind, A. S. Asch, E. Ceserman, M. C. Gershengorn, and E. A. Mesri. 1998. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391:86-89.
7. Beilharz, M. W., W. McDonald, M. W. Watson, J. Heng, J. McGeachie, and C. M. Lawson. 1997. Low-dose oral type I interferons reduce early virus replication of murine cytomegalovirus in vivo. J. Interferon Cytokine Res. 17:725-630.
8. Belardelli, F., and I. Gresser. 1996. The neglected role of type I Interferon in the T-cell response: implications for its clinical use. Immunol. Today 17:369-372.
9. Beral, V. 1991. Epidemiology of Kaposi's sarcoma. Cancer Surv. 10:5-22.
10. Blasig, C., C. Zietz, B. Haar, F. Neipel, S. Esser, N. H. Brockmeyer, E. Tschachler, S. Colombini, B. Ensoli, and M. Stürzl. 1997. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus-8. J. Virol. 71:7963-7968.
11. Boshoff, C., D. Whitby, T. Hatzioannou, C. Fisher, J. van der Wilt, J. Hatzakis, R. Weiss, and T. Schulz. 1995. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 345:1043-1044.
12. Boshoff, C., Y. Endo, P. D. Collins, Y. Takeuchi, J. D. Reeves, V. L. Scweickart, M. A. Siani, T. Sasaki, T. J. Williams, P. W. Gray, P. S. Moore, Y. Chang, and R. A. Weiss. 1997. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278:290-292.
13. Cesarman, E., Y. Chang, P. S. Moore, J. W. Said, and D. M. Knowles. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186-1191.
14. Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
15. Cordero, E., F. L. Lopez-Cortes, P. Viciana, A. Alarcon, and J. Pachon. 1997. Foscarnet and AIDS-associated Kaposi's sarcoma. AIDS 11:1787-1788.
16. Costa da Cunha, C. S., C. Lebbe, M. Rybojad, F. Agbalika, F. Ferchal, C. Rabian, M. D. Vignon-Pennamen, F. Calvo, and P. Morel. 1996. Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b. Arch. Dermatol. 132:285-290.
17. Davis, M. A., M. Stürzl, C. Blasig, A. Schreier, H. G. Guo, M. Reitz, S. R. Opalenik, and P. J. Browning. 1997. Expression of human herpesvirus 8-encoded cylin D in Kaposi's sarcoma spindle cells. J. Natl. Cancer Inst. 89: 1868-1871.
18. Decker, L. L., P. Shankar, G. Khan, R. B. Freeman, B. J. Dezube, J. Lieberman, and D. A. Thorley-Lawson. 1996. The Kaposi's sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J. Exp. Med. 184:283-288.
19. Delcayre, A. X., M. Lotz, and W. Lernhardt. 1993. Inhibition of Epstein-Barr virus-mediated capping of CD21/CR2 by alpha interferon (IFN-α): immediate antiviral activity of IFN-α during the early phase of infection. J. Virol. 67:2918-2921.
20. De Lellis, L., M. Fabris, F. Cassai, A. Corallini, G. Giraldo, C. Feo, and P. Monini. 1995. Herpesvirus-like DNA sequences in non-AIDS Kaposi's sarcoma. J. Infect. Dis. 172:1605-1607.
21. De Wit, R., J. K. M. E. Shattenkerk, C. A. B. Boucher, P. J. M. Bakker, K. H. N. Veenhof, and S. A. Danner. 1988. Clinical and virological effects of high-dose recombinant inteferon-alpha in disseminated AIDS-related Kaposi's sarcoma. Lancet 11:1214-1217.
22. Dorfman, R. F., and F. R. C. Path. 1984. The histogenesis of Kaposi's sarcoma. Lymphology 17:76-77.
23. Eid, P., and M. G. Tovey. 1995. Characterization of a domain of a human type I interferon receptor protein involved in ligand binding. J. Interferon Cytokine Res. 15:295-211.
24. Ensoli, B., P. Markham, V. Kao, G. Barillari, V. Fiorelli, R. Gendelman, M. Raffeld, G. Zon, and R. C. Gallo. 1994. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis and lesion formation in nude mice by anti-sense oligonucleotides targeting basic fibroblast growth factor: a novel strategy for the therapy of KS. J. Clin. Investig. 94:1736-1746.
25. Ensoli, B., and M. Stürzl. 1998. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 9:63-83.
26. Ensoli, B., and R. C. Gallo. 1994. Growth factors in AIDS-associated Kaposi's sarcoma: cytokines and HIV-1 Tat protein. AIDS Updates 7:1-12.
27. Ensoli, B., R. Gendelman, P. Markham, V. Fiorelli, S. Colombini, R. Raffeld, A. Cafaro, H. K. Chang, J. N. Brady, and R. C. Gallo. 1994. Synergy between basic fibroblast growth factor and human immunodeficiency virus type 1 Tat protein in induction of Kaposi's sarcoma. Nature 371:674-680.
28. Feduchi, E., and L. Carrasco. 1991. Mechanism of inhibition of HSV-1 replication by tumor necrosis factor and inteferon-γ. Virology 180:822-825.
29. Feduchi, E., A. M. Alonso, and L. Carrasco. 1989. Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63:1354-1359.
30. + T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with HIV-1 Tat protein: an immune response to HHV-8 infection? Blood 91:956-967.
31. Flemington, E., and S. H. Speck. 1990. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64:1217-1226.
32. Gao, S., C. Boshoff, S. Javachandra, R. A. Weiss, Y. Chang, and P. S. Moore. 1997. KSHV ORF K9 (vIRF) in an oncogene which inhibits the interferon signaling pathway. Oncogene 15:1979-1985.
33. Gao, S., L. Kingsley, D. R. Hoover, T. J. Spira, C. R. Rinaldo, A. Saah, J. Phair, R. Detels, P. Parry, Y. Chang, and P. S. Moore. 1996. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N. Eng. J. Med. 335:233-241.
34. Goletti, D., P. Monini, S. Colombini, P. Leone, A. Cafaro, M. Stürzl, M. Franco, P. Leone, F. Citterio, R. Little, and B. Ensoli. Expanded tropism of Human Herpesvirus-8 for hematopoietic-derived cells upon Kaposi's sarcoma development. Submitted for publication.
35. Gribaudo, G., S. Ravaglia, M. Gaboli, M. Gariglio, R. Cavallo, and S. Landolfo. 1995. Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity. Virology 211:251-260.
36. Gridelli, C., G. Palmieri, G. Airoma, P. Incoronato, R. Pepe, E. Barra, and A. R. Bianco. 1990. Complete regression of laryngeal involvement by classic Kaposi's sarcoma with low-dose alpha-2b interferon. Tumori 76:292-293.
37. Hankel, H., M. R. Capobianchi, F. Frezza, C. Castilletti, and F. Dianzani. 1996. Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. Virology 221:113-119.
38. Harrington, W. J., O. Bagasra, C. E. Sosa, L. E. Bobroski, M. Baum, X. L. Wen, L. Cabral, G. E. Byrne, R. J. Pomerantz, and C. Wood. 1996. Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J. Infect. Dis. 174:1101-1105.
39. Kedes, D. H., and D. Ganem. 1997. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. J. Clin. Investig. 9:2082-2086.
40. Kledal, T. N., M. M. Rosenkilde, F. Coulin, G. Simmons, A. H. Johnsen, S. Alouani, C. A. Power, H. R. Luttichau, J. Gerstoft, P. R. Clapham, I. Clark-Lewis, T. N. C. Wells, and T. W. Schwartz. 1997. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 277:1656-1659.
41. Köster, R., L. M. Blatt, M. Streubert, C. Zietz, H. Hermeking, W. Brysch, and M. Stürzl. 1996. Consensus-interferon and platelet-derived growth factor adversely regulate proliferation and migration of Kaposi's sarcoma cells by control of c-myc expression. Am. J. Pathol. 149:1871-1885.
42. Krown, S. E. 1998. Interferon-alpha: evolving therapy for AIDS-associate Kaposi's sarcoma. J. Interferon Cytokine Res. 18:209-214.
43. Krown, S. E., F. X. Real, S. Cunningham-Rundles, P. Myskowski, B. Koziner, S. Fein, A. Mittelman, H. F. Oettgen, and B. Safai. 1983. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N. Engl. J. Med. 308:1071-1076.
44. Lagunoff, M., and D. Ganem. 1997. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). Virology 236:147-154.
45. Lucin, P., S. Jonjic, M. Messerle, B. Polic, H. Hengel, and U. H. Koszidowski. 1994. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumor necrosis factor. J. Gen. Virol. 75:101-110.
46. Luka, J., B. Kallin, and G. Klein. 1979. Induction of Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94:228-231.
47. Lvovsky, E., P. H. Levine, D. Fuccillo, D. V. Ablashi, Z. H. Bengali, G. R. Armstrong, and H. B. Levy. 1981. Epstein-Barr virus and herpesvirus saimiri: sensitivity to interferons and interferon inducers. JNCI 66:1013-1019.
48. MacPhail, L. A., N. P. Dekker, and J. A. Regezi. 1996. Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma. J. Cutaneous Pathol. 23:464-472.
49. McNutt, N. S., V. Fletcher, and M. A. Conant. 1983. Early lesions of Kaposi's sarcoma in homosexual men. An ultrastructural comparison with other vascular proliferations in skin. Am. J. Pathol. 111:62-77.
50. Medveczky, M. M., E. Horvath, T. Lund, and P. G. Medveczky. 1997. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS 11:1327-1332.
51. Mesri, E. A., E. Cesarman, L. Arvanitakis, S. Rafii, M. A. Moore, D. N. Posnett, D. M. Knowles, and A. S. Asch. 1996. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J. Exp. Med. 183:2385-2390.
52. Mittnacht, S., P. Straub, H. Kirchner, and H. Jacobsen. 1988. Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology 164:201-210.
53. Moore, P. S., and Y. Chang. 1995. Detection of herpesvirus-like sequences in Kaposi's sarcoma in patients with and those without HIV infection. N. Engl. J. Med. 332:1181-1185.
54. Moore, P. S., C. Boshoff, R. A. Weiss, and Y. Chang. 1996. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739-1744.
55. Moore, P. S., L. Kingsley, S. D. Holmberg, T. Spira, P. Gupta, D. R. Hoover, J. P. Parry, L. J. Conley, H. W. Jaffe, and Y. Chang. 1996. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 10:175-180.
56. Morfeldt, L., and J. Torssander. 1994. Long-term remission of Kaposi's sarcoma following Foscarnet treatment in HIV-infected patients. Scand. J. Infect. Dis. 26:749-752.
57. Morris, A., and A. W. Valley. 1996. Overview of the management of AIDS-related Kaposi's sarcoma. Ann. Pharmacother. 30:1150-1163.
58. Munoz, A., and L. Carrasco. 1984. Formation of non-infective herpesvirus particles in cultured cells treated with human interferon. J. Gen. Virol. 65:1069-1078.
59. Neipel, F., J. C. Albrecht, and B. Fleckenstein. 1997. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J. Virol. 71:4187-4192.
60. Oberman, F., and A. Panet. 1988. Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells. J. Gen. Virol. 69:1167-1177.
61. Orenstein, J. M., S. Alkan, A. Blauvelt, K. T. Jeang, M. D. Weinstein, D. Ganem, and B. Herndier. 1997. Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS 11: 35-45.
62. Real, F. X., H. F. Oettgen, and S. E. Krown. 1986. Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon. J. Clin. Oncol. 4:544-551.
63. Regezi, S. A., L. A. MacPhail, T. E. Daniels, Y. G. De Souza, J. S. Greenspan, and D. Greenspan. 1993. Human immunodeficiency virus-associated oral Kaposi's sarcoma: a heterogeneous cell population dominated by spindle-shaped endothelial cells. Am. J. Pathol. 43:240-249.
64. Renne, R., W. Zhong, B. Herndier, M. McGrath, M. Abbey, D. Kedes, and D. Ganem. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:342-346.
65. Rezza, G., M. Andreoni, M. Dorrucci, P. Pezzotti, P. Monini, R. Zerboni, B. Salassa, V. Colangeli, L. Sarmati, E. Nicastri, A. Sinicco, R., Pristerà, G. Angarano, F. Aiuti, L. Ortona, and B. Ensoli. Human herpesvirus-8 sero-positivity and risk of developing Kaposi's sarcoma and other AIDS-related diseases among individuals with known dates of HIV seroconversion. J. Natl. Cancer Inst., in press.
66. Russo, J. J., R. A. Bohenzky, M. C. Chien, J. Chen, M. Yan, D. Maddalena, J. P. Parry, D. Peruzzi, I. S. Edelman, and Y. Chang. 1996. Nucleotide sequence of the Kaposi's sarcoma-associated herpesvirus (HHV-8). Proc. Natl. Acad. Sci. USA 93:14862-14867.
67. Safai, B., and R. A. Good. 1980. Kaposi's sarcoma: a review and recent developments. Clin. Bull. 10:62-69.
68. Samaniego, F., P. D. Markham, R. Gendelman, R. C. Gallo, and B. Ensoli. 1997. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J. Immunol. 158:1887-1894.
69. Samaniego, F., P. D. Markham, R. Gendelman, Y. Watanabe, V. Kao, K. Kowalski, J. A. Sonnabend, A. Pintus, R. C. Gallo, and B. Ensoli. 1998. Vascular endothelial growth factor and basic fibroblast growth factor are expressed in Kaposi's sarcoma and synergize to induce angiogenesis, vascular permeability and KS lesion development: induction by inflammatory cytokines. Am. J. Pathol. 152:1433-1443.
70. Sarid, R., O. Fiore, R. A. Bohenzky, Y., Chang, and P. S. Moore. 1998. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J. Virol. 72:1005-1012.
71. Schalling, M., M. Ekman, E. E. Kaaya, A. Linde, and P. Biberfeld. 1995. A role for a new herpesvirus (KSHV) in different forms of Kaposi's sarcoma. Nature Med. 1:707-708.
72. Sen, G. C., and R. M. Ransohoff. 1993. Interferon-induced antiviral actions and their regulation. Adv. Virus. Res. 42:57-102.
73. Singh, R. K., M. Gutman, C. D, Bucana, R. Sanchez, N. Llansa, and I. J. Fidler. 1995. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc. Nat. Acad. Sci. USA 92:4562-4566.
74. Sirianni, M. C. 1997. Human herpesvirus-8 DNA sequences in CD8+ T cells. J. Infect. Dis. 176:541.
75. Sirianni, M. C., L. Vincenzi, V. Fiorelli, S. Topino, E. Scala, S. Uccini, A. Angeloni, A. Faggioni, D. Cerimele, F. Cottoni, F. Aiuti, and B. Ensoli. 1998. γ-Interferon production in peripheral blood mononuclear cells (PBMC) and tumour infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in PBMC and lesional macrophages. Blood 91:968-976.
76. Sirianni, M. C., S. Uccini, A. Angeloni, A. Faggioni. F. Cottoni, and B. Ensoli. 1997. Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma. Lancet 349:225.
77. Soulier, J., L. Grollet, E. Oksenhendler, J. M. Miclea, P. Cacoub, A. Baruchel, P. Brice, J. P. Clauvel, M. F. d'Agay, M. Raphel, L. Degos, and F. Sigaux. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280.
78. Staeheli, P., F. Pitossi, and J. Pavlovic. 1993. Mx proteins: GTPases with antiviral activity. Trends Cell Biol. 3:268-272.
79. Staskus, K. A., W. Zhong, K. Gebhard, B. Herndier, H. Wang, R. Renne, J. Beneke, J. Pudney, D. J. Anderson, D. Ganem, and A. T. Hasse. 1997. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71:715-719.
80. Stürzl, M., A. Schreir, G. Ascherl, C. Hohenadl, P. Monini, C. Zietz, P. J. Browning, F. Neipel, P. Biberfeld, and B. Ensoli. Human herpesvirus-8 (HHV-8) gene expression in Kaposi's sarcoma (KS) primary lesions: an in situ hybridization study. Leukemia, in press.
81. Stürzl, M., C. Blasig, A. Schreier, F. Neipel, C. Hohenadl, E. Cornali, G. Ascherl, S. Esser, N. H. Brockmeyer, M. Ekman, E. E. Kaaya, E. Tschachler, and P. Biberfeld. 1997. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma (KS). Int. J. Cancer 72:68-71.
82. Sun, R., S. F. Lin, L. Gradoville, and G. Miller. 1996. Plyadenylylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 93:11883-11888.
83. Thiele, K., and H. Kirchner. 1988. Effects of different interferons on the replication of herpes simplex virus in human T lymphocytes. J. Interferon Res. 8:507-515.
84. Tilg, H. 1997. New insights into the mechanisms of Interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology 112: 1017-1021.
85. Toraldo, R., M. D'Avanzo, C. Tolone, G. Canino, F. Iafusco, L. D. Notarangelo, A. Ugazio, and C. Cirillo. 1995. Effect of interferon-alpha therapy in a patient with common variable immunodeficiency and chronic Epstein-Barr virus infection. Pediatr. Hematol. Oncol. 12:489-493.
86. Tur, E., S. Brenner, and R. Michalevicz. 1993. Low dose recombinant interferon alfa treatment for classic Kaposi's sarcoma. Arch. Dermatol. 129:1297-1300.
87. Uccini, S., M. C. Sirianni, L. Vincenzi, S. Topino, A. Stoppacciaro, I. Lesnoni La Parola, M. Capuano, C. Masini, D. Cerimele, M. Cella, A. Lanzavecchia, P. Allavena, A. Mantovani, C. D. Baroni, and L. P. Ruco. 1997. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am. J. Pathol. 150:929-938.
88. Whitby, D., M. R. Howard, M. Tenant-Flowers, N. S. Brink, A. Copas, C. Boshoff, T. Hatzioannou, F. E. Suggett, D. M. Aldam, A. S. Denton, R. F. Miller, I. V. D. Weller, R. A. Weiss, R. S. Tedder, and T. F. Schulz. 1995. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346: 799-803.
89. Yeow, W. S, C. M. Lcawson, and M. W. Beilharz. 1998. Antiviral activities of individual murine IFN-alpha subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication. J. Immunol. 160: 2932-2939.
90. Zimring, J. C., S. Goodbourn, and M. K. Offerman. 1998. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J. Virol. 72:701-707.
91. Zhong, W., H. Wang, B. Herndier, and D. Ganem. 1996. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi's sarcoma. Proc. Natl. Acad. Sci. USA 93:6641-6646.